IMOVAX RABIES (rabies virus strain pm-1503-3m antigen- propiolactone inactivated and water kit Bandaríkin - enska - NLM (National Library of Medicine)

imovax rabies (rabies virus strain pm-1503-3m antigen- propiolactone inactivated and water kit

sanofi pasteur inc. - rabies virus strain pm-1503-3m antigen (propiolactone inactivated) (unii: c4hqf74xmw) (rabies virus strain pm-1503-3m antigen (propiolactone inactivated) - unii:c4hqf74xmw) - rabies virus strain pm-1503-3m antigen (propiolactone inactivated) 2.5 [iu] in 1 ml - imovax rabies is a vaccine indicated for pre-exposure and post-exposure prophylaxis against rabies. imovax rabies vaccine is approved for use in all age groups. physicians must evaluate each possible rabies exposure. local or state public health officials should be consulted if questions arise about the need for prophylaxis. (11) the following factors should be considered before antirabies prophylaxis is initiated. rabid bats have been documented in the 49 continental states, and bats are increasingly implicated as important wildlife reservoirs for variants of rabies virus transmitted to humans. transmission of rabies virus can occur from minor, seemingly underappreciated or unrecognized bites from bats (see table 2). (11) raccoons, skunks, and foxes are the terrestrial carnivores most often infected with rabies in the united states. suggestive clinical signs of rabies among wildlife cannot be interpreted reliably. all bites by such wildlife should be considered possible exposures to rabies virus. post-exposu

Rabies Vaccine BP > 2.5 IU/ml, Powder and solvent for suspension for injection Írland - enska - HPRA (Health Products Regulatory Authority)

rabies vaccine bp > 2.5 iu/ml, powder and solvent for suspension for injection

sanofi pasteur - inactivated rabies virus strain pm/wi 38 1503 3m - powder and solvent for suspension for injection - 2.5 international unit(s)/millilitre - rabies vaccines; rabies, inactivated, whole virus

Versiguard Rabies, suspension for injection Írland - enska - HPRA (Health Products Regulatory Authority)

versiguard rabies, suspension for injection

zoetis belgium s.a. - inactivated rabies virus, strain vnukovo-32 - suspension for injection - minimum 2.0 international unit(s) - rabies virus - cats, cattle, dogs, ferrets, goats, horses, pigs, sheep - immunological - inactivated vaccine

Verorab, powder and solvent for suspension for injection.                                                                           Rabies vaccine, inactivated. Írland - enska - HPRA (Health Products Regulatory Authority)

verorab, powder and solvent for suspension for injection. rabies vaccine, inactivated.

sanofi pasteur - rabies virus (inactivated) strain wistar (pm/wi 38-1503-3m) - powder and solvent for suspension for injection in pre-filled syringe - rabies, inactivated, whole virus

NOBIVAC RABIES Írland - enska - HPRA (Health Products Regulatory Authority)

nobivac rabies

intervet ireland limited - rabies virus strain pasteur riv inactivated - suspension for injection - unknown - rabies virus vaccine - canine, feline - immunological - inactivated vaccine

VERSIGUARD RABIES, SUSPENSION FOR INJECTION Írland - enska - HPRA (Health Products Regulatory Authority)

versiguard rabies, suspension for injection

zoetis ireland limited - inactivated rabies virus, strain vnukovo-32 - suspension for injection - unknown - rabies virus vaccine - bovine, canine, caprine, equine - food, feline, ferret, ovine, porcine - immunological - inactivated vaccine

VERORAB Ísrael - enska - Ministry of Health

verorab

sanofi israel ltd - rabies, inactivated, whole virus - powder and solvent for suspension for injection - rabies, inactivated, whole virus 2.5 iu - rabies, inactivated, whole virus - rabies, inactivated, whole virus - prevention of rabies in children and adults. it can be used before and after exposure, as a primary vaccination or as a booster dose.

Merieux Inactivated Rabies Vaccine (MIRV) Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

merieux inactivated rabies vaccine (mirv)

pharmacy retailing (nz) ltd t/a healthcare logistics - rabies vaccine, wistar pm/wi 38-1503-3m 2.5 [iu] - suspension for injection - 2.5 iu - active: rabies vaccine, wistar pm/wi 38-1503-3m 2.5 [iu] excipient: albumin neomycin sulfate water for injection - post exposure immunisation against rabies. pre-exposure immunisation in persons at special risk of contracting rabies.

RABAVERT- rabies vaccine kit Bandaríkin - enska - NLM (National Library of Medicine)

rabavert- rabies vaccine kit

glaxosmithkline biologicals sa - rabies virus strain flury lep antigen (propiolactone inactivated) (unii: fk894q51ye) (rabies virus strain flury lep antigen (propiolactone inactivated) - unii:fk894q51ye) - rabies virus strain flury lep antigen (propiolactone inactivated) 2.5 [iu] in 1 ml - rabavert is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups. usually an immunization series is initiated and completed with 1 vaccine product. no clinical studies have been conducted that document a change in efficacy or the frequency of adverse reactions when the series is completed with a second vaccine product. however, for booster immunization, rabavert was shown to elicit protective antibody level responses in persons tested who received a primary series with hdcv.4,11 preexposure vaccination: see table 1 and dosage and administration. preexposure vaccination consists of 3 doses of rabavert 1.0 ml given intramuscularly (deltoid region), 1 each on days 0, 7, and 21 or 281 (see also table 1 for criteria for preexposure vaccination). preexposure vaccination does not eliminate the need for additional therapy after a known rabies exposure (see dosage and administration: postexposure prophylaxis of previously im